ChemicalBook > CAS DataBase List > Gatifloxacin

Gatifloxacin

Product Name
Gatifloxacin
CAS No.
112811-59-3
Chemical Name
Gatifloxacin
Synonyms
Zymar;TEQUIN;CG5501;S)-AHPC;Gatiquin;PD135432;PD 135432;PD-135432);BMS-206584;GASTRODINUM
CBNumber
CB2726045
Molecular Formula
C19H22FN3O4
Formula Weight
375.39
MOL File
112811-59-3.mol
More
Less

Gatifloxacin Property

Melting point:
162°C
Boiling point:
607.8±55.0 °C(Predicted)
Density 
1.386±0.06 g/cm3(Predicted)
storage temp. 
Sealed in dry,2-8°C
solubility 
Chloroform (Slightly, Heated), Methanol (Slightly, Heated)
pka
6.43±0.50(Predicted)
form 
White to yellow crystalline powder.
color 
White to Off-White
InChI
InChI=1S/C19H22FN3O4/c1-10-8-22(6-5-21-10)16-14(20)7-12-15(18(16)27-2)23(11-3-4-11)9-13(17(12)24)19(25)26/h7,9-11,21H,3-6,8H2,1-2H3,(H,25,26)
InChIKey
XUBOMFCQGDBHNK-UHFFFAOYSA-N
SMILES
N1(C2CC2)C2=C(C=C(F)C(N3CCNC(C)C3)=C2OC)C(=O)C(C(O)=O)=C1
CAS DataBase Reference
112811-59-3(CAS DataBase Reference)
More
Less

Safety

Hazard Codes 
Xn
Risk Statements 
20/21/22
Safety Statements 
36/37
HS Code 
29335990
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P271Use only outdoors or in a well-ventilated area.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P304+P340IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

P312Call a POISON CENTER or doctor/physician if you feel unwell.

P403+P233Store in a well-ventilated place. Keep container tightly closed.

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
14290
Product name
Gatifloxacin
Purity
≥98%
Packaging
1g
Price
$44
Updated
2024/03/01
Cayman Chemical
Product number
14290
Product name
Gatifloxacin
Purity
≥98%
Packaging
5g
Price
$193
Updated
2024/03/01
Cayman Chemical
Product number
14290
Product name
Gatifloxacin
Purity
≥98%
Packaging
10g
Price
$341
Updated
2024/03/01
TRC
Product number
G250000
Product name
Gatifloxacin
Packaging
100g
Price
$230
Updated
2021/12/16
Usbiological
Product number
255362
Product name
Gatifloxacin
Packaging
50mg
Price
$339
Updated
2021/12/16
More
Less

Gatifloxacin Chemical Properties,Usage,Production

Description

Gatifloxacin belongs to a class of drugs known as quinolone antibiotics and is used to treat acute sinus, lung, or urinary tract infections and sexually transmitted bacterial infection.This drug may be taken orally, in tablet form, or by injection.Common side effects associated with gatifloxacin include nausea, vaginitis(irritation or inflammation of the vagina),diarrhea, headache, dizziness, and irregular heart beats. In general, gatifloxacin is used in people who are unresponsive to other AOM therapies.
In one study, gatifloxacin was compared with amoxicillin/clavulanate in the treatment of recurrent otitis media (OM) and AOM in treatment failures in children.Three hundred fifty-four infants and children with recurrent OM or AOM failure received gatifloxacin or amoxicillin/clavulanate.Results showed that both drugs were well tolerated; the most common side effect was diarrhea.Researchers concluded that treatment with gatifloxacin once daily was as effective as amoxicillin/clavulanate twice daily.In other medical literature, gatifloxacin has been noted as a third-line treatment option in AOM.

Chemical Properties

White to light yellow powder

Uses

An antibacterial.

Definition

ChEBI: A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an anti iotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.

brand name

Tequin (Bristol-Myers Squibb); Zymar (Allergan).

Antimicrobial activity

Gatifloxacin is an 8-methoxyfluoroquinolone with enhanced activity against Gram-positive, atypical agents, and some anerobes, and broad-spectrum activity against Gram-negative bacteria. It is bactericidal and produces a post-antibiotic effect in Gram-positive and Gramnegative bacteria.
The in vitro antibacterial spectrum of gatifloxacin has been tested against a variety of clinically important microorganisms. It is two to four times more potent than ciprofloxacin and ofloxacin against staphylococci, streptococci, pneumococci, and enterococci. However, it is two times less potent than ciprofloxacin, but the same as or two times more potent than ofloxacin against Enterobacteriaceae. Gatifloxacin and ofloxacin have similar antipseudomonal activity, while ciprofloxacin is two to eight times more potent. Gatifloxacin is highly potent against Hemophilus influenzae, Legionella species, and Helicobacter pylori, and also has activity against Bacteroides fragilis and Clostridium difficile. Like other quinolones, it has poor activity against Mycobacterium avium intracellulare, but is 8–16 times more potent against Mycobacterium tuberculosis.
Meyler's Side Effects of Drugs || Gatifloxacin

Pharmaceutical Applications

The spectrum includes Acinetobacter spp. and Aeromonas spp. but it is not very active against Ps. aeruginosa and other non-fermentative Gram-negative rods. It is more active against methicillin-susceptible strains of staphylococci than methicillin-resistant strains. It is also active against Chlamydia, Mycoplasma and Legionella spp. and has some activity against anaerobes.
It is almost completely absorbed when given orally and is widely distributed throughout the body into many body tissues and fluids. The plasma half-life is 6–8 h. More than 70% of the drug is excreted unchanged in the urine. Renal clearance is reduced by 57% in moderate renal insufficiency and by 77% in severe renal insufficiency.
Prolongation of the QTc interval in some patients and interference with diabetes mellitus have resulted in withdrawal of the drug in most countries for systemic usage. Gatifloxacin remains in use in North America only as an ophthalmic solution.

Biological Activity

Fluoroquinolone antibiotic. Inhibits bacterial type II topoisomerases (IC 50 values are 0.109 and 13.8 μ g/ml for E.coli DNA gyrase and S.aureus topoisomerase IV respectively). Displays potent activity against gram-positive and gram-negative bacteria. Stimulates short-term self-renewal in both human and mouse embryonic stem cells in vitro .

Mechanism of action

Gatifloxacin is a quinolone antimicrobial. It is an 8-methoxyfluoroquinolone with a 3-methylpiperazinyl substituent at C7. The antibacterial action of gatifloxacin results from inhibition of DNA gyrase and topoisomerase IV. DNA gyrase is an essential enzyme that is involved in the replication, transcription, and repair of bacterial DNA. Topoisomerase IV is an enzyme known to play a key role in the partitioning of the chromosomal DNA during bacterial cell division. The mechanism of action of fluoroquinolones including gatifloxacin is different from that of aminoglycoside, macrolide, and tetracycline antibiotics. Therefore, gatifloxacin may be active against pathogens that are resistant to these antibiotics and these antibiotics may be active against pathogens that are resistant to gatifloxacin. There is no cross-resistance between gatifloxacin and the aforementioned classes of antibiotics. Cross-resistance has been observed between systemic gatifloxacin and some other fluoroquinolones.
https://www.accessdata.fda.gov

Pharmacokinetics

Gatifloxacin ophthalmic solution 0.5% was administered to one eye of 6 healthy male subjects each in an escalated dosing regimen starting with a single 2 drop dose, then 2 drops 4 times daily for 7 days, and finally 2 drops 8 times daily for 3 days. At all time points, serum gatifloxacin levels were below the lower limit of quantification (5 ng/mL) in all subjects.

Side effects

Gatifloxacin is well absorbed from the gastrointestinal tract (oral availability almost 100%), and concomitant administration of a continental breakfast, 1050 kcal, had no effect on its availability. The standard dose is 400 mg od and both oral and intravenous formulations are available.
Common side effects
Worsening of eye infection
Eye irritation
Eye pain
Change in taste
The following serious adverse reactions are described elsewhere in the labeling:
Hypersensitivity [see Contraindications (4) and Warnings and Precautions (5.1)]
Growth of Resistant Organisms With Prolonged Use [see Warnings and Precautions (5.2)]
Corneal Endothelial Cell Injury [see Warnings and Precautions (5.3)]
https://go.drugbank.com
https://medlineplus.gov
https://www.accessdata.fda.gov

storage

+4°C

Gatifloxacin Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Gatifloxacin Suppliers

JIANGSU SZYY Group Pharmaceutical Limited
Tel
0523-88851180
Email
scb@szyy.cn
Country
China
ProdList
4
Advantage
60
Hefei Lifeon Pharmaceutical Co.Ltd.
Tel
0551-65328450 18956095011
Fax
0551-65324089
Email
sales@lifeon.cn
Country
China
ProdList
23
Advantage
58
Shanghai Boyle Chemical Co., Ltd.
Tel
021-50182298 021-50180596
Fax
+86-21-57758967
Email
sales@boylechem.com
Country
China
ProdList
2210
Advantage
55
J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Fax
86-10-82849933
Email
jkinfo@jkchemical.com
Country
China
ProdList
96815
Advantage
76
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Fax
86-21-50328109
Email
3bsc@sina.com
Country
China
ProdList
15848
Advantage
69
future industrial shanghai co., ltd
Tel
400-0066400 13621662912
Fax
021-55660885
Email
sales@jonln.com
Country
China
ProdList
1998
Advantage
65
Energy Chemical
Tel
021-021-58432009 400-005-6266
Fax
021-58436166
Email
sales8178@energy-chemical.com
Country
China
ProdList
44751
Advantage
61
Adamas Reagent, Ltd.
Tel
400-6009262 16621234537
Fax
021-64823266
Email
zhangsn@titansci.com
Country
China
ProdList
14113
Advantage
59
LGM Pharma
Tel
1-(800)-881-8210
Fax
615-250-9817
Email
inquiries@lgmpharma.com
Country
United States
ProdList
2127
Advantage
70
Chemsky(shanghai)International Co.,Ltd.
Tel
021-50135380
Email
shchemsky@sina.com
Country
China
ProdList
32344
Advantage
50
More
Less

View Lastest Price from Gatifloxacin manufacturers

Henan Suikang Pharmaceutical Co.,Ltd.
Product
Gatifloxacin 112811-59-3
Price
US $0.00/kg
Min. Order
25kg
Purity
99.0%
Supply Ability
10tons
Release date
2024-04-25
WUHAN CIRCLE POWDER TECHNOLOGY CO.,LTD
Product
Gatifloxacin 112811-59-3
Price
US $0.00/KG
Min. Order
100g
Purity
98%+
Supply Ability
100kg
Release date
2020-11-30
Hebei Yanxi Chemical Co., Ltd.
Product
Gatifloxacin 112811-59-3
Price
US $0.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
20tons
Release date
2023-09-26

112811-59-3, GatifloxacinRelated Search:


  • GATIFLOXACIN
  • 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid
  • 1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-8-METHOXY-7-(3-METHYLPIPERAZIN-1-YL)-4-OXO-3-QUINOLINECARBOXYLIC ACID
  • 1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDROXY-8-METHOXY-7-(3-METHYL-1-PIPERAZINYL)-4-OXO-3-QUINOLINECARBOXYLIC ACID
  • Gatifloxacin API
  • Gatiquin
  • AM 1155;BMS 206584-01;PD 135432;AM1155;BMS206584-01;PD135432;AM-1155;PD-135432
  • BMS 206584-01
  • BMS206584-01
  • PD 135432
  • PD135432
  • PD-135432)
  • 1-CYCLOPROPYL-6-FLUORO-8-METHOXY-7-(3-METHYL-PIPERAZIN-1-YL)-4-OXO-1,4-DIHYDRO-QUINOLINE-3-CARBOXYLIC ACID
  • AKOS NCG1-0010
  • TEQUIN
  • Gatifloxacin(AM-1155)
  • Zymar
  • GASTRODINUM
  • 1-cyclopropyl-6-fluoro-4-keto-8-methoxy-7-(3-methylpiperazin-1-yl)quinoline-3-carboxylic acid
  • 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid
  • 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid
  • 1-cyclopropyl-6-fluoro-8-Methoxy-7-[(3S)-3-Methylpiperazin-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
  • 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-(3-Methyl-1-piperazinyl)-4-oxo-
  • 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-(3-Methyl-1-piperazinyl)-4-oxo-3-quinoli
  • CG5501
  • BMS-206584
  • (±)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid sesquihydrate sesquihydrate
  • Gatifloxacin synthetic
  • Gatifloxacin 1.5H20
  • 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid USP/EP/BP
  • 1-Cyclopropyl-6-fluoro-1
  • 4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid
  • Gatifloxacin Impurity M
  • Gatifloxacin piperazine
  • 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-4-ium-1-yl)-4-oxoquinoline-3-carboxylate
  • GatifloxacinQ: What is Gatifloxacin Q: What is the CAS Number of Gatifloxacin Q: What is the storage condition of Gatifloxacin Q: What are the applications of Gatifloxacin
  • 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid
  • S)-AHPC
  • And for the effect of
  • 112811-59-3
  • 112811-59-8
  • C19H22FN3O4
  • C19H22FN3O45H2O
  • 37539
  • Pharmaceutical intermediates
  • Gatiflo, Tequin and Zymar
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • API's
  • API
  • 112811-59-3